Showing results (361-370 of 408) with videos related to
Sort By:
Pageof 41
Immunity|April 29, 2014
Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimersEmilia Falkowska, Khoa M Le, Alejandra Ramos, et al.Nature Medicine|September 28, 2018
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individualsYotam Bar-On, Henning Gruell, Till Schoofs, et al.Nature|May 31, 2019
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaquesAmelia Escolano, Harry B Gristick, Morgan E Abernathy, et al.NPJ Vaccines|January 11, 2022
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamstersLisa H Tostanoski, Abishek Chandrashekar, Shivani Patel, et al.Cell|August 1, 2021
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spikePei Tong, Avneesh Gautam, Ian W Windsor, et al.Science Translational Medicine|January 24, 2024
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of ImmunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.Nature|June 25, 2016
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruptionJohannes F Scheid, Joshua A Horwitz, Yotam Bar-On, et al.Science Immunology|February 10, 2023
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animalsHarry B Gristick, Harald Hartweger, Maximilian Loewe, et al.Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.Pageof 41